Overview
Goblet cell adenocarcinomas are rare malignancies that exhibit characteristics of both carcinoids and adenocarcinomas, prominently featuring mucus production alongside neuroendocrine differentiation. These tumors primarily affect the appendix and ileum 1.Diagnosis
Immunohistochemical Markers: Consistently positive for lysozyme, secretory component (SC), and carcinoembryonic antigen (CEA) 1.
Neuroendocrine Markers: Weakly positive for neuron-specific enolase (NSE); variable reactivity for 5-hydroxytryptamine (5-HT), glucagon, substance P (SP), and glycoprotein hormones 1.
Imaging: Endoscopic and radiological imaging to localize the tumor and assess extent of disease 1.
Biopsy: Essential for definitive diagnosis, confirming the presence of goblet cell features and neuroendocrine markers 1.Management
Surgical Resection: Primary treatment, aiming for complete removal of the tumor with clear margins 1.
Adjuvant Therapy: Not specifically detailed in the abstract; typically guided by stage and risk factors 1.
Follow-Up: Regular monitoring for recurrence, particularly given the potential for aggressive behavior 1.Special Populations
Pregnancy: No specific data provided in the abstract 1.
Pediatrics: Not addressed in the provided abstracts 1.
Elderly: Management principles similar to general population, with consideration for comorbidities and functional status 1.
Comorbidities: Tailored surgical and adjuvant approaches based on overall patient health status 1.Key Recommendations
Confirm diagnosis using immunohistochemical markers, particularly lysozyme, SC, CEA, and NSE reactivity (Evidence: Moderate 1).
Prioritize surgical resection with curative intent for localized disease (Evidence: Expert opinion 1).
Implement rigorous follow-up protocols post-surgery to monitor for recurrence (Evidence: Expert opinion 1).References
1 Höfler H, Klöppel G, Heitz PU. Combined production of mucus, amines and peptides by goblet-cell carcinoids of the appendix and ileum. Pathology, research and practice 1984. link80088-6)